| Market Capitalization (Millions $) |
4,932 |
| Shares
Outstanding (Millions) |
274 |
| Employees |
118 |
| Revenues (TTM) (Millions $) |
3 |
| Net Income (TTM) (Millions $) |
-67 |
| Cash Flow (TTM) (Millions $) |
150 |
| Capital Exp. (TTM) (Millions $) |
0 |
Puretech Health Plc
PureTech Health Plc, founded in 2002, is a biotechnology company that focuses on developing and commercializing innovative treatments for various healthcare challenges. The company aims to address significant medical needs by utilizing strategic partnerships and collaborations with leading academic institutions, scientific entrepreneurs, and industry experts.
PureTech Health has a unique approach to healthcare innovation, employing a cross-disciplinary team of experts in various fields, including biology, medicine, engineering, and data science. This interdisciplinary approach allows the company to explore diverse technologies and treatment modalities, including microbiome-based therapies, targeted drug delivery systems, and digital health solutions.
The company operates through an internal pipeline of wholly-owned subsidiaries, such as Karuna Therapeutics, Gelesis, Vedanta Biosciences, and Akili Interactive, among others. Each subsidiary focuses on a specific therapeutic area or technological platform, allowing for efficient development and commercialization of their respective products.
PureTech Health Plc's innovation-driven business model aims to identify and validate emerging science and technology, shepherd them through clinical development, and ultimately launch them as successful, commercially viable products. With a strong emphasis on collaboration and intellectual property, the company strives to position itself at the forefront of healthcare innovation.
Company Address: 6 Tide Street Boston 2210 MA
Company Phone Number: 482-2333 Stock Exchange / Ticker: NASDAQ PRTC
|
2.27%